Evaluate NrF2 Activation and Anti-Fibrotic Effects in Mouse Models of Fibrosis In Vivo

  • Varga, John (PD/PI)
  • Wei, Jun (Co-Investigator)

Project: Research project

Project Details


This SRA supports understanding whether Nrf2 agonists may be an important therapeutic target for tissue injury and fibrosis and specifically whether this might be a target in scleroderma.
Effective start/end date12/16/136/16/16


  • Biogen Inc. (Agmt 12/16/13)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.